Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02197728
Other study ID # 13-326
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date December 2015

Study information

Verified date February 2019
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We hypothesize, that the use of the Hohl manipulator® at total laparoscopic hysterectomy reduces operative time (from skin incision to detachment of the uterus) and lateral termal damage of the vaginal wall during colpotomy due to the following reasons: (1) Uterine manipulation is better with the Hohl manipulator®, thereby facilitating dissection during all aspects of the surgery, (2) more tension can be applied on the vagina during colpotomy, thereby hastening electrosurgical transection, reducing activation time and reduce lateral thermal damage and (3) tension on the vagina can be applied until the colpotomy is finished, due to the tight connection between the Hohl manipulator® and the cervix of the uterus, which also affects speed of transection, electrosurgical device activation time and lateral thermal damage.


Recruitment information / eligibility

Status Completed
Enrollment 91
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- All women aged over 18 years, scheduled for a laparoscopic hysterectomy for a benign disorder will be asked to participate and included after written informed consent.

Exclusion Criteria:

- pregnancy

- malignancy

- if uterine size exceeds 20 weeks of gestation

- or if the uterus could be removed by a vaginal approach

Study Design


Related Conditions & MeSH terms

  • Laparoscopic Hysterectomy for Benign Conditions

Intervention

Device:
Use of the Colpo-Probeā„¢ Vaginal Fornix Delineator or Hohl manipulator® during total laparoscopic hysterectomy


Locations

Country Name City State
Canada St. Michael´s Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detachment of the uterus Operative time from skin incision to detachment of uterus. Times are routinely collected by operating room nursing staff. 45 minutes to 3 hours
Primary Thermal Damage Lateral thermal damage to the vagina will be measured on the specimen (in mm) at the time of pathologic evaluation. 2 weeks post surgery
Primary Colpotomy Time from first monopolar energy activation to completion of colpotomy. Operative times are routinely collected by operating room nursing staff. 3 minutes to 20 minutes
Secondary Blood Loss Total amount of blood lost throughout surgery. Measured in cc. 45 minutes to 3 hours
Secondary Pain Amount of post operative pain measured using a pain sensitivity scale. 24h post surgery
Secondary Manipulator Installment intraoperative
See also
  Status Clinical Trial Phase
Recruiting NCT06195176 - Randomized Clinical Trial: Effect of an Exercise Routine on Postoperative Shoulder Pain in Laparoscopic Hysterectomy N/A